Neonatal Intensive Care Unit, S.Orsola-Malpighi Hospital
Bologna, 40138, Italy
NCT Number: NCT03643458
Since 1987, red blood cell (RBC) transfusions have been proposed as a potential risk factor for necrotizing enterocolitis (NEC), which is one of the most severe gastrointestinal complications of prematurity.
Evidence from Doppler studies have shown a post-transfusion impairment of mesenteric blood flow in response to feeds, whereas NIRS studies have reported transient changes of splanchnic oxygenation after RBC transfusion; a possible role for these findings in increasing the risk for TANEC development has been hypothesized.
The aim of this study is to evaluate SrSO2 patterns in response to enteral feeding before and after transfusion.
Looking for future studies?
Notify Me1 day–3 month
All sexes
Observational
Bologna, 40138, Italy
Premature neonates are among the most transfused population, but the risks and benefits of this procedure remain unclear. Since 1987, red blood cell (RBC) transfusions have been proposed as a potential risk factor for necrotizing enterocolitis (NEC), which is one of the most common and feared gastrointestinal complications of prematurity. Several observational studies have tried to demonstrate this causal correlation, defining the so-called transfusion-associated NEC (TANEC), which occurs within 48 hours after RBC transfusion.
Evidence from Doppler studies have shown a post-transfusion impairment of mesenteric blood flow in response to feeds, whereas NIRS studies have reported transient changes of splanchnic oxygenation after RBC transfusion. This evidence, which has been hypothesized to play a role on the risk of TANEC development, has significantly raised the attention over the feeding plans during and after RBC transfusion.
To date, splanchnic oxygenation response to feeds before and after transfusion has not been investigated, but could bring useful information to understand the splanchnic hemodynamic changes associated to RBC transfusion.
Therefore, the aim of this study is to evaluate SrSO2 patterns in response to enteral feeding before and after transfusion.
Enrolled infants will undergo a 12-h monitoring of cerebral (CrSO2) and splanchnic (SrSO2) oxygenation, performed using an INVOS 5100 oxymeter (Medtronic, Boulder, CO), whose neonatal sensors will be placed in the central region of the forehead and the below the umbilicus, respectively.
The study monitoring includes the following phases:
CrSO2 and SrSO2 patterns before and after transfusion and the related changes from baseline values will be analyzed. SCOR (CrSO2/SrSO2 ratio) patterns will be also calculated and analyzed. IBM SPSS Statistics (Statistical Package for the Social Sciences, SPSS Inc., IBM, Armonk, NY) will be used for statistical analysis. If any infant develops TANEC after transfusion, the related patterns will be evaluated and analyzed separately.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Enteral feed before red blood cell transfusion administration (3 hours)
Decrease or increase of splanchnic oxygenation during and after feed administration compared to pre-prandial baseline value
Time frame: Enteral feed after red blood cell transfusion administration (3 hours)
Decrease or increase of splanchnic oxygenation during and after feed administration compared to pre-prandial baseline value
Time frame: 48 hours after transfusion
Occurrence of necrotizing enterocolitis or feeding intolerance in infants undergone red blood cell transfusion
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Other
Splanchnic Oxygenation in Response to Enteral Feeds Before and After Red Blood Cell Transfusion in Preterm Infants
Acronym: NIRS_RBC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05170633
Blood Transfusion Complication, Body Temperature Changes
Columbia, South Carolina, United States
View Trial DetailsNCT04833556
Anesthesia Complication, Blood Transfusion Complication
Bangkok, Thailand
View Trial DetailsNCT06889272
Acute Kidney Injury, Acute Renal Injury
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04866953
Blood Transfusion Complication, Death
Los Angeles, California, United States
View Trial Details